These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24906491)

  • 1. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double-blind, placebo-controlled trial.
    Costello JM; Dunbar-Masterson C; Allan CK; Gauvreau K; Newburger JW; McGowan FX; Wessel DL; Mayer JE; Salvin JW; Dionne RE; Laussen PC
    Circ Heart Fail; 2014 Jul; 7(4):596-604. PubMed ID: 24906491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients.
    Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA
    Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Nesiritide Infusion on Early Postoperative Recovery After Total Cavopulmonary Connection Surgery.
    Zhang Y; Duan Y; Yan J; Wang Q; Li S; Xu H
    Pediatr Cardiol; 2018 Dec; 39(8):1598-1603. PubMed ID: 29998377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind Randomized Clinical Pilot Study Comparing Dobutamine and Milrinone.
    Cavigelli-Brunner A; Hug MI; Dave H; Baenziger O; Buerki C; Bettex D; Cannizzaro V; Balmer C
    Pediatr Crit Care Med; 2018 Jul; 19(7):619-625. PubMed ID: 29538053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effect of two regimens of milrinone infusion in pediatric patients undergoing fontan procedure: A randomized study.
    Soliman R; Ragheb A
    Ann Card Anaesth; 2018; 21(2):134-140. PubMed ID: 29652273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.
    Chen HH; Sundt TM; Cook DJ; Heublein DM; Burnett JC
    Circulation; 2007 Sep; 116(11 Suppl):I134-8. PubMed ID: 17846293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
    Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparative study of intravenous infusion of three different fixed doses of milrinone in pediatric patients with pulmonary hypertension undergoing open heart surgery.
    Barnwal NK; Umbarkar SR; Sarkar MS; Dias RJ
    Ann Card Anaesth; 2017; 20(3):318-322. PubMed ID: 28701597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
    Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H
    Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics.
    Hoffman TM; Wernovsky G; Atz AM; Bailey JM; Akbary A; Kocsis JF; Nelson DP; Chang AC; Kulik TJ; Spray TL; Wessel DL
    Am Heart J; 2002 Jan; 143(1):15-21. PubMed ID: 11773907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Vasopressin After Fontan Completion: A Randomized Pilot Study.
    Bigelow AM; Ghanayem NS; Thompson NE; Scott JP; Cassidy LD; Woods KJ; Woods RK; Mitchell ME; Hraŝka V; Hoffman GM
    Ann Thorac Surg; 2019 Dec; 108(6):1865-1874. PubMed ID: 31400337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial.
    Jebeli M; Ghazinoor M; Mandegar MH; Rasouli MR; Eghtesadi-Araghi P; Goodarzynejad H; Mohammadzadeh R; Darehzereshki A; Dianat S
    Cardiol J; 2010; 17(1):73-8. PubMed ID: 20104460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
    Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
    Thorlacius EM; Suominen PK; Wåhlander H; Keski-Nisula J; Vistnes M; Ricksten SE; Synnergren M; Romlin BS; Castellheim A
    Pediatr Crit Care Med; 2019 Oct; 20(10):947-956. PubMed ID: 31274775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative effects and safety of nesiritide following cardiac surgery in children.
    Simsic JM; Scheurer M; Tobias JD; Berkenbosch J; Schechter W; Madera F; Weinstein S; Michler RE
    J Intensive Care Med; 2006; 21(1):22-6. PubMed ID: 16698741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial.
    Mentzer RM; Oz MC; Sladen RN; Graeve AH; Hebeler RF; Luber JM; Smedira NG;
    J Am Coll Cardiol; 2007 Feb; 49(6):716-26. PubMed ID: 17291938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.